Last reviewed · How we verify

NCT05546801: UDiPPP

Antenatal Ultrasound Diagnosis of Periventricular Pseudocysts and Postnatal Outcome

Completed NA Last updated 22 February 2023
What this trial tests

NA trial testing questionnaire in Periventricular Pseudocysts in 46 participants. Completed in 1 December 2022.

Timeline
12 October 2022
Primary endpoint
1 December 2022
1 December 2022

Quick facts

Lead sponsorUniversity Hospital, Bordeaux
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment46
Start date12 October 2022
Primary completion1 December 2022
Estimated completion1 December 2022
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

University Hospital, Bordeaux

Who can join

Adults 0 to 5, any sex, with Periventricular Pseudocysts. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The present study aims to improve the information given to the parents during the screening of periventricular pseudocysts in the Pluridisciplinary Center of Prenatal Diagnosis, with retrospective cases screened during the last 5 years in university hospital of Bordeaux.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of questionnaire

Trials testing the same drug.

Other University Hospital, Bordeaux trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05546801.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing